BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 21199769)

  • 1. Monoamine transporters: vulnerable and vital doorkeepers.
    Lin Z; Canales JJ; Björgvinsson T; Thomsen M; Qu H; Liu QR; Torres GE; Caine SB
    Prog Mol Biol Transl Sci; 2011; 98():1-46. PubMed ID: 21199769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of monoamine transporters.
    Glatt CE; Reus VI
    Pharmacogenomics; 2003 Sep; 4(5):583-96. PubMed ID: 12943466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters.
    Vaughan RA
    J Pharmacol Exp Ther; 2004 Jul; 310(1):1-7. PubMed ID: 15064332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters.
    Kolhatkar R; Cook CD; Ghorai SK; Deschamps J; Beardsley PM; Reith ME; Dutta AK
    J Med Chem; 2004 Oct; 47(21):5101-13. PubMed ID: 15456254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine transporter inhibitors and substrates as treatments for stimulant abuse.
    Howell LL; Negus SS
    Adv Pharmacol; 2014; 69():129-76. PubMed ID: 24484977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity.
    Miller GM; Yatin SM; De La Garza R; Goulet M; Madras BK
    Brain Res Mol Brain Res; 2001 Feb; 87(1):124-43. PubMed ID: 11223167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of psychostimulants, antidepressants, and other inhibitors of synaptic neurotransmitter uptake by the plasma membrane monoamine transporters.
    Surratt CK; Ukairo OT; Ramanujapuram S
    AAPS J; 2005 Oct; 7(3):E739-51. PubMed ID: 16353950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Function of monoamine neurotransmitter transporters].
    Sasa M
    Nihon Rinsho; 2001 Aug; 59(8):1457-64. PubMed ID: 11519142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A splice variant of the Drosophila vesicular monoamine transporter contains a conserved trafficking domain and functions in the storage of dopamine, serotonin, and octopamine.
    Greer CL; Grygoruk A; Patton DE; Ley B; Romero-Calderon R; Chang HY; Houshyar R; Bainton RJ; Diantonio A; Krantz DE
    J Neurobiol; 2005 Sep; 64(3):239-58. PubMed ID: 15849736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of Expression of Drug Transporters: Methods for Appraisal.
    Gromicho M; Rueff J; Rodrigues AS
    Methods Mol Biol; 2016; 1395():75-85. PubMed ID: 26910070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions.
    Hall FS; Li XF; Sora I; Xu F; Caron M; Lesch KP; Murphy DL; Uhl GR
    Neuroscience; 2002; 115(1):153-61. PubMed ID: 12401330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and molecular aspects of monoamine neurotransmitter transporters.
    Kitayama S; Dohi T
    Jpn J Pharmacol; 1996 Nov; 72(3):195-208. PubMed ID: 8957680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3.
    Duan H; Wang J
    J Pharmacol Exp Ther; 2010 Dec; 335(3):743-53. PubMed ID: 20858707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.
    Froimowitz M; Wu KM; Moussa A; Haidar RM; Jurayj J; George C; Gardner EL
    J Med Chem; 2000 Dec; 43(26):4981-92. PubMed ID: 11150168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters.
    Miller DK; Crooks PA; Zheng G; Grinevich VP; Norrholm SD; Dwoskin LP
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1035-45. PubMed ID: 15121762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-type-specific expression of catecholamine transporters in the rat brain.
    Lorang D; Amara SG; Simerly RB
    J Neurosci; 1994 Aug; 14(8):4903-14. PubMed ID: 8046459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells.
    Nishimura M; Sato K; Okada T; Yoshiya I; Schloss P; Shimada S; Tohyama M
    Anesthesiology; 1998 Mar; 88(3):768-74. PubMed ID: 9523822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of monoamine transporters: Role of transporter phosphorylation.
    Ramamoorthy S; Shippenberg TS; Jayanthi LD
    Pharmacol Ther; 2011 Feb; 129(2):220-38. PubMed ID: 20951731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors.
    Olivier B; Soudijn W; van Wijngaarden I
    Prog Drug Res; 2000; 54():59-119. PubMed ID: 10857386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter.
    Jayanthi LD; Apparsundaram S; Malone MD; Ward E; Miller DM; Eppler M; Blakely RD
    Mol Pharmacol; 1998 Oct; 54(4):601-9. PubMed ID: 9765501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.